Date

Tuesday, 14 June 2022

Location

European Medicines Agency, Amsterdam, the Netherlands

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Documents

Agenda of the COMP meeting 14-16 June 2022

COMP meeting report on the review of applications for orphan designation: June 2022

How useful do you find this page?